At A Glance Summaries

02.04.25

Improving understanding of the complex relationship between environmental factors and psoriasis through self-reported data: First findings from the mySkin study

The first findings from the mySkin study have been published in the British Journal of Dermatology (full paper available online here), delivering insight into the environmental factors that trigger the onset or worsening of psoriasis.

The mySkin project, launched in June 2023, has been co-developed by…

17.02.24

Acceptability of ‘as needed’ biologic therapy in psoriasis: insights from a multistakeholder mixed-methods study.

Research published in the British Journal of Dermatology provides an overview of ‘as needed’ biologic therapy and its reception from people with psoriasis and healthcare professionals.

The full paper is available online here and the study is summarised below…

18.09.24

Exploring the link between Genetic Predictors of Cardiovascular Disease and Psoriasis

Evidence that genetic predictors of cardiovascular diseases also increase psoriasis risk

Our recent study explores the link between genetic predictors of cardiovascular diseases and their connection to psoriasis, a chronic skin condition…

30.01.24

Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade.

New research maps early skin changes in people receiving successful psoriasis treatment.

Research published in Nature Communications provides a cell atlas of psoriasis skin during the first two weeks of biologic treatment. The full paper is available online here and you can read an overview of the study…

01.09.23

Real-World Implementation and Outcomes of Adalimumab Therapeutic Drug Monitoring in Psoriasis: A National Specialized Centre Experience

New research published in the Journal of Investigative Dermatology shows that blood tests to measure adalimumab concentration may help patients and form part of routine psoriasis care.

Psoriasis occurs when the immune system becomes overactive. Dermatologists can treat more severe psoriasis with a class of medication called ‘biologics’. One such medication is adalimumab…